BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33413142)

  • 1. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.
    Mantelli S; Jungo KT; Rozsnyai Z; Reeve E; Luymes CH; Poortvliet RKE; Chiolero A; Rodondi N; Gussekloo J; Streit S
    BMC Fam Pract; 2018 Oct; 19(1):169. PubMed ID: 30314468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial.
    Jungo KT; Meier R; Valeri F; Schwab N; Schneider C; Reeve E; Spruit M; Schwenkglenks M; Rodondi N; Streit S
    BMC Fam Pract; 2021 Jun; 22(1):123. PubMed ID: 34157981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing for older adults in Australia: factors influencing GPs.
    Gillespie R; Mullan J; Harrison L
    Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitude towards deprescribing and its association with frailty and complexity of medication regimen: A survey of older inpatients in a district health board in New Zealand.
    Mohammed MA; Harrison J; Milosavljevic A; Chan AHY
    BMC Geriatr; 2023 Mar; 23(1):166. PubMed ID: 36959598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially inappropriate medication and attitudes of older adults towards deprescribing.
    Achterhof AB; Rozsnyai Z; Reeve E; Jungo KT; Floriani C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    PLoS One; 2020; 15(10):e0240463. PubMed ID: 33104695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
    Gillespie R; Mullan J; Harrison L
    Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe.
    Shrestha S; Giri R; Sapkota HP; Danai SS; Saleem A; Devkota S; Shrestha S; Adhikari B; Poudel A
    Ther Adv Drug Saf; 2021; 12():20420986211019309. PubMed ID: 34211689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MediQuit - an electronic deprescribing tool: a pilot study in German primary care; GPs' and patients' perspectives.
    Michiels-Corsten M; Gerlach N; Junius-Walker U; Schleef T; Donner-Banzhoff N; Viniol A
    BMC Prim Care; 2022 Sep; 23(1):252. PubMed ID: 36162994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Older Adult Health Literacy in the Day-to-Day Management of Polypharmacy and Making Decisions About Deprescribing: A Mixed Methods Study.
    Gillespie R; Mullan J; Harrison L
    Health Lit Res Pract; 2023 Jan; 7(1):e14-e25. PubMed ID: 36629783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing in older patients by early-career general practitioners: Prevalence and associations.
    Magin P; Quain D; Tapley A; van Driel M; Davey A; Holliday E; Ball J; Kaniah A; Turner R; Spike N; FitzGerald K; Hilmer S
    Int J Clin Pract; 2021 Aug; 75(8):e14325. PubMed ID: 33960089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding older patients' willingness to have medications deprescribed in primary care: a protocol for a cross-sectional survey study in nine European countries.
    Lüthold RV; Jungo KT; Weir KR; Geier AK; Scholtes B; Kurpas D; Wild DMG; Petrazzuoli F; Thulesius H; Lingner H; Assenova R; Poortvliet RKE; Lazic V; Rozsnyai Z; Streit S
    BMC Geriatr; 2022 Nov; 22(1):920. PubMed ID: 36451180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.